Overview

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to describe the time course and extent of hemoglobin (Hb) changes and the erythropoietic response to PEG-IFN/RBV (Pegylated Interferon and Ribavirin)-induced anemia In HCV(hepatitis C virus)/HIV (human immunodeficiency virus) co-Infected subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Ortho Biotech Products, L.P.
Treatments:
Interferons
Ribavirin